Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Novo Nordisk (NYSE:NVO) in the last three months.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 8 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 2 | 0 | 0 | 0 |
| 3M Ago | 0 | 4 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $160.38, a high estimate of $163.00, and a low estimate of $160.00. This current average represents a 0.77% decrease from the previous average price target of $161.62.
Investigating Analyst Ratings: An Elaborate Study
The perception of Novo Nordisk by...
Login or create a forever free account to read this news
Sign up/Log in